CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities
Net income (loss)	$ 20,861	$ (36,636)
Less: net loss from discontinued operations	0	2,734
Adjustments to reconcile net income (loss) to net cash flows from operating activities:
Depreciation, amortization and share-based compensation	1,761	2,062
Net realized (gains) losses on investment	(11,038)	11,101
Total other-than-temporary impairment losses	1,506	0
Foreign exchange and other gains	(8,181)	(4,964)
Changes in assets – (increase) decrease:
Reinsurance balances receivable, net	(15,205)	(7,198)
Reinsurance recoverable on unpaid losses	2,256	(36)
Accrued investment income	(1,659)	2
Deferred commission and other acquisition expenses	7,438	88,388
Funds withheld receivable	1,261	(53,741)
Other assets	(8,464)	(3,462)
Changes in liabilities – increase (decrease):
Reserve for loss and loss adjustment expenses	(174,835)	(67,641)
Unearned premiums	(20,479)	(326,214)
Accrued expenses and other liabilities	(13,703)	63,880
Net cash used in continuing operations	(218,481)	(331,725)
Net cash used in discontinued operations	0	(205)
Net cash used in operating activities	(218,481)	(331,930)
Cash flows from investing activities:
Purchases of fixed maturities	(133,353)	(159,790)
Purchases of other investments	(2,325)	(1,528)
Proceeds from sales of fixed maturities	224,471	84,361
Proceeds from maturities, paydowns and calls of fixed maturities	200,242	206,811
Proceeds from sale and redemption of other investments	92	406
Other, net	(597)	2,870
Net cash provided by investing activities for continuing operations	288,530	133,130
Net cash used in investing activities for discontinued operations	0	(3,349)
Net cash provided by investing activities	288,530	129,781
Effect of exchange rate changes on foreign currency cash, restricted cash and equivalents	635	(334)
Net increase (decrease) in cash, restricted cash and cash equivalents	70,684	(202,483)
Cash, restricted cash and cash equivalents, beginning of period	107,278	337,102
Cash, restricted cash and cash equivalents, end of period	177,962	134,619
Less: cash, restricted cash and equivalents of discontinued operations, end of period	0	(2,764)
Cash, restricted cash and cash equivalents of continuing operations, end of period	177,962	131,855
Reconciliation of cash and restricted cash reported within Condensed Consolidated Balance Sheets:
Cash and cash equivalents, end of period	60,059	89,521
Restricted cash and cash equivalents	117,903	42,334
AmTrust Quota Shares Reinsurance Agreement, Partial Termination Amendment
Non-cash investing activities
Investments transferred out	0	280,670
Funds Withheld Arrangement
Non-cash investing activities
Investments transferred out	$ 0	$ 571,396